|
Market Analysis Reports of Losartan Impurity C
|
Valsartan Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type ... N-nitrosodimethylamine (NDMA), a carcinogenic impurity. Additionally, in April 2021, the ... impurities in some ARB APIs, leading to further recalls of valsartan, irbesartan, and losartan ... Control Innovations: Advances in impurity-free manufacturing processes, ...
Global API of Sartan Drugs Market Research Report 2025(Status and Outlook) ... receptor blockers (ARBs) such as valsartan, losartan, and irbesartan, is driven by their ... issues, particularly with nitrosamine impurities, leading to stricter quality control ... Medicine Market Segmentation (by Type) Losartan API Valsartan API Irbesartan ...
|
|
|